209 related articles for article (PubMed ID: 31147930)
1. Trimming of MHC Class I Ligands by ERAP Aminopeptidases.
Weimershaus M; Evnouchidou I; Li L; van Endert P; Bouvier M
Methods Mol Biol; 2019; 1988():31-43. PubMed ID: 31147930
[TBL] [Abstract][Full Text] [Related]
2. Peptide Trimming for MHC Class I Presentation by Endoplasmic Reticulum Aminopeptidases.
Compagnone M; Fruci D
Methods Mol Biol; 2019; 1988():45-57. PubMed ID: 31147931
[TBL] [Abstract][Full Text] [Related]
3. ERAP1 enzyme-mediated trimming and structural analyses of MHC I-bound precursor peptides yield novel insights into antigen processing and presentation.
Li L; Batliwala M; Bouvier M
J Biol Chem; 2019 Dec; 294(49):18534-18544. PubMed ID: 31601650
[TBL] [Abstract][Full Text] [Related]
4. ERAP1-ERAP2 dimers trim MHC I-bound precursor peptides; implications for understanding peptide editing.
Chen H; Li L; Weimershaus M; Evnouchidou I; van Endert P; Bouvier M
Sci Rep; 2016 Aug; 6():28902. PubMed ID: 27514473
[TBL] [Abstract][Full Text] [Related]
5. Peptide trimming by endoplasmic reticulum aminopeptidases: Role of MHC class I binding and ERAP dimerization.
Evnouchidou I; van Endert P
Hum Immunol; 2019 May; 80(5):290-295. PubMed ID: 30682405
[TBL] [Abstract][Full Text] [Related]
6. ERAP1-ERAP2 dimerization increases peptide-trimming efficiency.
Evnouchidou I; Weimershaus M; Saveanu L; van Endert P
J Immunol; 2014 Jul; 193(2):901-8. PubMed ID: 24928998
[TBL] [Abstract][Full Text] [Related]
7. The partial dissociation of MHC class I-bound peptides exposes their N terminus to trimming by endoplasmic reticulum aminopeptidase 1.
Papakyriakou A; Reeves E; Beton M; Mikolajek H; Douglas L; Cooper G; Elliott T; Werner JM; James E
J Biol Chem; 2018 May; 293(20):7538-7548. PubMed ID: 29599287
[TBL] [Abstract][Full Text] [Related]
8. An Overview on ERAP Roles in Infectious Diseases.
Saulle I; Vicentini C; Clerici M; Biasin M
Cells; 2020 Mar; 9(3):. PubMed ID: 32183384
[TBL] [Abstract][Full Text] [Related]
9. The role of endoplasmic reticulum aminopeptidases in type 1 diabetes mellitus.
Limanaqi F; Vicentini C; Saulle I; Clerici M; Biasin M
Life Sci; 2023 Jun; 323():121701. PubMed ID: 37059356
[TBL] [Abstract][Full Text] [Related]
10. Regulation of ERAP1 and ERAP2 genes and their disfunction in human cancer.
Compagnone M; Cifaldi L; Fruci D
Hum Immunol; 2019 May; 80(5):318-324. PubMed ID: 30825518
[TBL] [Abstract][Full Text] [Related]
11. The ERAP1 active site cannot productively access the N-terminus of antigenic peptide precursors stably bound onto MHC class I.
Mavridis G; Mpakali A; Zoidakis J; Makridakis M; Vlahou A; Kaloumenou E; Ziotopoulou A; Georgiadis D; Papakyriakou A; Stratikos E
Sci Rep; 2021 Aug; 11(1):16475. PubMed ID: 34389743
[TBL] [Abstract][Full Text] [Related]
12. The ER Aminopeptidases, ERAP1 and ERAP2, synergize to self-modulate their respective activities.
MartÃn-Esteban A; Rodriguez JC; Peske D; Lopez de Castro JA; Shastri N; Sadegh-Nasseri S
Front Immunol; 2022; 13():1066483. PubMed ID: 36569828
[TBL] [Abstract][Full Text] [Related]
13. Influence of ERAP1 and ERAP2 gene polymorphisms on disease susceptibility in different populations.
Yao Y; Liu N; Zhou Z; Shi L
Hum Immunol; 2019 May; 80(5):325-334. PubMed ID: 30797823
[TBL] [Abstract][Full Text] [Related]
14. Endoplasmic reticulum aminopeptidases: Biology and pathogenic potential.
Haroon N; Inman RD
Nat Rev Rheumatol; 2010 Aug; 6(8):461-7. PubMed ID: 20531381
[TBL] [Abstract][Full Text] [Related]
15. Expression of endoplasmic reticulum aminopeptidases in EBV-B cell lines from healthy donors and in leukemia/lymphoma, carcinoma, and melanoma cell lines.
Fruci D; Ferracuti S; Limongi MZ; Cunsolo V; Giorda E; Fraioli R; Sibilio L; Carroll O; Hattori A; van Endert PM; Giacomini P
J Immunol; 2006 Apr; 176(8):4869-79. PubMed ID: 16585582
[TBL] [Abstract][Full Text] [Related]
16. Placental leucine aminopeptidase efficiently generates mature antigenic peptides in vitro but in patterns distinct from endoplasmic reticulum aminopeptidase 1.
Georgiadou D; Hearn A; Evnouchidou I; Chroni A; Leondiadis L; York IA; Rock KL; Stratikos E
J Immunol; 2010 Aug; 185(3):1584-92. PubMed ID: 20592285
[TBL] [Abstract][Full Text] [Related]
17. ERAP1 shapes just part of the immunopeptidome.
Admon A
Hum Immunol; 2019 May; 80(5):296-301. PubMed ID: 30849449
[TBL] [Abstract][Full Text] [Related]
18. Peptidases trimming MHC class I ligands.
Weimershaus M; Evnouchidou I; Saveanu L; van Endert P
Curr Opin Immunol; 2013 Feb; 25(1):90-6. PubMed ID: 23089230
[TBL] [Abstract][Full Text] [Related]
19. Concerted peptide trimming by human ERAP1 and ERAP2 aminopeptidase complexes in the endoplasmic reticulum.
Saveanu L; Carroll O; Lindo V; Del Val M; Lopez D; Lepelletier Y; Greer F; Schomburg L; Fruci D; Niedermann G; van Endert PM
Nat Immunol; 2005 Jul; 6(7):689-97. PubMed ID: 15908954
[TBL] [Abstract][Full Text] [Related]
20. Editing the immunopeptidome of melanoma cells using a potent inhibitor of endoplasmic reticulum aminopeptidase 1 (ERAP1).
Koumantou D; Barnea E; Martin-Esteban A; Maben Z; Papakyriakou A; Mpakali A; Kokkala P; Pratsinis H; Georgiadis D; Stern LJ; Admon A; Stratikos E
Cancer Immunol Immunother; 2019 Aug; 68(8):1245-1261. PubMed ID: 31222486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
